Asthma remission: what is it and how can it be achieved?
Thomas D, McDonald VM, Pavord ID, Gibson PG.
Eur Respir J. 2022 Nov 3;60(5):2102583. doi: 10.1183/13993003.02583-2021. Print 2022 Nov.
Immortal time bias in pharmaco-epidemiology.
Suissa S.
Am J Epidemiol. 2008 Feb 15;167(4):492-9. doi: 10.1093/aje/kwm324. Epub 2007 Dec 3.
Classification of Cough as a Symptom in Adults and Management Algorithms: CHEST Guideline and Expert Panel Report.
Irwin RS, French CL, Chang AB, Altman KW; CHEST Expert Cough Panel*.
Chest. 2018 Jan;153(1):196-209. doi: 10.1016/j.chest.2017.10.016. Epub 2017 Nov 10.
Management of chronic refractory cough in adults.
Visca D, Beghè B, Fabbri LM, Papi A, Spanevello A.
Eur J Intern Med. 2020 Nov;81:15-21. doi: 10.1016/j.ejim.2020.09.008. Epub 2020 Sep 19.
Bronchial asthma.
George RB, Owens MW.
Dis Mon. 1991 Mar;37(3):137-96. doi: 10.1016/0011-5029(91)90017-6.
Statins for asthma.
Naing C, Ni H.
Cochrane Database Syst Rev. 2020 Jul 15;7(7):CD013268. doi: 10.1002/14651858.CD013268.pub2.
Pre-biologic disease trajectories are associated with morbidity burden and biologic treatment response in severe asthma.
Soendergaard MB, Hjortdahl F, Hansen S, Bjerrum AS, von Bülow A, Hilberg O, Bonnesen Bertelsen B, Johnsen CR, Lock-Johansson S, Vijdea R, Rasmussen LM, Schmid JM, Ulrik CS, Porsbjerg C, Håkansson KEJ.
Eur Respir J. 2025 Apr 3;65(4):2401497. doi: 10.1183/13993003.01497-2024. Print 2025 Apr.
Common respiratory diseases.
Kilgore D, Najm W.
Prim Care. 2010 Jun;37(2):297-324. doi: 10.1016/j.pop.2010.02.007.
Safety and Tolerability of Twice-Yearly Depemokimab in Patients with Asthma and Chronic Rhinosinusitis with Nasal Polyps: Pooled Results from SWIFT-1/-2 and ANCHOR-1/-2.
Jackson DJ, Bourdin A, Blackorby A, Leslie A, Vichiendilokkul A, Howarth P, Karkoszka N, Fujieda S, Cornet M.
Adv Ther. 2026 Feb;43(2):880-897. doi: 10.1007/s12325-025-03457-4. Epub 2025 Dec 29.
Occupational asthma.
Newman Taylor AJ.
Postgrad Med J. 1988 Jul;64(753):505-10. doi: 10.1136/pgmj.64.753.505.
